COVID-19 vaccine patch heads to the clinic
To view this email as a web page, click here

Today's Rundown

Featured Story

Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech

Chugai Pharmaceutical has struck a deal for a subcutaneous drug delivery technology, paying Halozyme Therapeutics $25 million upfront to use its Enhanze enzyme against an undisclosed target.

read more

Top Stories

Bankruptcy court clears Purdue to fund low-cost opioid rescue medication

A bankruptcy court has boosted Harm Reduction Therapeutics’ (HRT) bid to develop a low-cost opioid rescue medication. With the court handling Purdue Pharma’s case approving the transfer of cash to HRT, the nonprofit drug developer is set to receive up to $11 million.

read more

Vaxxas strikes deal to tee up trial of COVID-19 vaccine patch

Vaxxas has secured an exclusive license to a SARS-CoV-2 spike protein from The University of Texas at Austin, positioning it to move a needle-free, room-temperature stable COVID-19 vaccine patch into the clinic.

read more

Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release drops

Optifye Therapeutics has struck a deal with DelSiTech for controlled-release dexamethasone eye drops. The exclusive license agreement covers a candidate that uses DelSiTech Silica Matrix technology to cut the number of times a day patients need to administer the eye drops.

read more

AAD 2022: Incyte's latest Opzelura data show med's benefit grows over time in vitiligo

As Incyte Corporation awaits the FDA’s decision on a second dermatology nod for eczema newcomer Opzelura, the company is rolling out fresh 52-week data showing the benefits of its topical JAK inhibitor increase over time.

read more

Resources

Industry Report: The Top Four Barriers to Successful KOL Engagement

Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now.

eBook: Leveraging Clinical Data for Study Success

The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates.

Whitepaper: Autologous CAR T-Cell Manufacturing: Semiautomatic, Closed, Modular Workflow

Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow.

eBook: EMEA Regulatory Roadblocks around Decentralized Trials

Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research.

Whitepaper: Top 5 Challenges Of Decentralized Clinical Trials And How To Overcome Them

How to overcome top challenges faced in decentralized trials.

Paid Marketplace: United Cargo: Providing comprehensive solutions for the most critical shipments

The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now.

Whitepaper: The Most Suitable Dosage Form Technologies for the Oral Delivery of Lipid-Based Formulations

What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations?

Case Study: Versatility of Softgel Technology - Encapsulation of a Volatile Compound

Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound.

Whitepaper: Lipid-Based Drug Delivery System to Bring Poorly Soluble Drugs to Market

How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market?

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

Events